• Title of article

    Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

  • Author/Authors

    Boogers، نويسنده , , Mark J. and Borleffs، نويسنده , , C. Jan Willem and Henneman، نويسنده , , Maureen M. and van Bommel، نويسنده , , Rutger J. and van Ramshorst، نويسنده , , Jan and Boersma، نويسنده , , Eric and Dibbets-Schneider، نويسنده , , Petra and Stokkel، نويسنده , , Marcel P. and van der Wall، نويسنده , , Ernst E. and Schalij، نويسنده , , Martin J. and Bax، نويسنده , , Jeroen J.، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2010
  • Pages
    9
  • From page
    2769
  • To page
    2777
  • Abstract
    Objectives rpose of this study was to evaluate whether 123-iodine metaiodobenzylguanidine (123-I MIBG) imaging predicts ventricular arrhythmias causing appropriate implantable cardioverter-defibrillator (ICD) therapy (primary end point) and the composite of appropriate ICD therapy or cardiac death (secondary end point). ound gh cardiac sympathetic denervation is associated with ventricular arrhythmias, limited data are available on the predictive value of sympathetic nerve imaging with 123-I MIBG on the occurrence of arrhythmias. s ICD implantation, patients underwent 123-I MIBG and myocardial perfusion imaging. Early and late 123-I MIBG (planar and single-photon emission computed tomography [SPECT]) imaging was performed to assess cardiac innervation (heart-to-mediastinum ratio, cardiac washout rate, and 123-I MIBG SPECT defect score). Stress-rest myocardial perfusion imaging was performed to assess myocardial infarction and perfusion abnormalities (perfusion defect scores). During follow-up, appropriate ICD therapy and cardiac death were documented. s ndred sixteen heart failure patients referred for ICD therapy were enrolled. During a mean follow-up of 23 ± 15 months, appropriate ICD therapy (primary end point) was documented in 24 (21%) patients and appropriate ICD therapy or cardiac death (secondary end point) in 32 (28%) patients. Late 123-I MIBG SPECT defect score was an independent predictor for both end points. Patients with a large late 123-I MIBG SPECT defect (summed score >26) showed significantly more appropriate ICD therapy (52% vs. 5%, p < 0.01) and appropriate ICD therapy or cardiac death (57% vs. 10%, p < 0.01) than patients with a small defect (summed score ≤26) at 3-year follow-up. sions c sympathetic denervation predicts ventricular arrhythmias causing appropriate ICD therapy as well as the composite of appropriate ICD therapy or cardiac death.
  • Keywords
    implantable cardioverter-defibrillator , 123-iodine metaiodobenzylguanidine imaging , sympathetic denervation , Ventricular arrhythmias
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    2010
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    1747736